Product guide · Under compliance review

Smart Brothers Noopept 60 caps

Specialised product from Smart Brothers, 60 capsules. This guide sets out what the manufacturer states about the composition of Smart Brothers Noopept 60 caps, what independent research says about its main ingredient, and the safety and regulatory points that apply. Its regulatory status is under compliance review. This guide is educational and does not recommend use.

Educational guide · Sources checked 4 November 2026 · 4 references

Back to the product

Named ingredients: 1
Amounts stated: All
Status: Under compliance review
Evidence summaries: 1

Overview

Manufacturer information

Smart Brothers Noopept 60 caps contains noopept (GVS-111, omberacetam): 30 mg. Each pack holds 60 capsules.

Ingredients & composition

Manufacturer information

Ingredient	Amount
Noopept (GVS-111, omberacetam)	30 mg

Scientific background

Independent research

Noopept (omberacetam)

Noopept (N-phenylacetyl-L-prolylglycine ethyl ester, omberacetam) is a synthetic compound described as an active pharmaceutical ingredient with nootropic activity¹.

Research evidence

Independent research

Noopept (omberacetam)

There are no robust controlled trials in healthy people showing improved memory or focus. Published research is mainly chemical, animal or from limited clinical settings¹.

Evidence limitations

Independent research

No published study has tested this specific product; the research summarised here concerns the ingredient itself.

Noopept (omberacetam)

Evidence in humans is very limited.

Safety & potential risks

Independent research

Noopept (omberacetam)

Human safety data are limited. Official medicines control laboratories in Europe and Australia have found illicit "smart drugs" sold as nootropic products and warn of their dangers².

Regulatory status

GIGACULT product information

Flagged for compliance review: this product is listed as a food supplement in our catalogue, but its EU status (food supplement, novel food or medicinal product) has not been verified. No benefits or health claims are made.

Regulation and sport

Noopept (omberacetam)

Noopept is not authorised as a food or food supplement ingredient in the EU³. Substances with a pharmacological action on the nervous system are regulated as medicinal products in the EU, and Noopept is not an authorised medicine⁴.

Scientific references

Araj SK, Szeleszczuk Ł, Gubica T, et al. Physicochemical and structural analysis of N-phenylacetyl-L-prolylglycine ethyl ester (Noopept): an active pharmaceutical ingredient with nootropic activity. J Pharm Biomed Anal. 2025;252:116474. PubMed 39298839
Vanhee C, Deconinck E, George M, et al. The occurrence of illicit smart drugs or nootropics in Europe and Australia and their associated dangers: results from a market surveillance study by 12 official medicines control laboratories. J Xenobiot. 2025;15:88. PubMed 40558871
Regulation (EU) 2015/2283 on novel foods. Official Journal of the European Union. Source
Directive 2001/83/EC on the Community code relating to medicinal products for human use. Official Journal of the European Union. Source

Sources checked against PubMed, Crossref or the official publisher on 2026-11-04. Manufacturer information is taken from the product's own data and has not been independently tested.

The product